The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Abdominal distension 5
METHYLPREDNISOLONE. Adverse event 5
METHYLPREDNISOLONE. Asthma 5
METHYLPREDNISOLONE. Bilirubin conjugated increased 5
METHYLPREDNISOLONE. Blood cholesterol increased 5
METHYLPREDNISOLONE. Blood urine present 5
METHYLPREDNISOLONE. Chest pain 5
METHYLPREDNISOLONE. Cough 5
METHYLPREDNISOLONE. Encephalopathy 5
METHYLPREDNISOLONE. Foetal exposure during pregnancy 5
METHYLPREDNISOLONE. Hepatic enzyme increased 5
METHYLPREDNISOLONE. Hepatic failure 5
METHYLPREDNISOLONE. High density lipoprotein increased 5
METHYLPREDNISOLONE. Hyperglycaemia 5
METHYLPREDNISOLONE. Low density lipoprotein decreased 5
METHYLPREDNISOLONE. Maternal drugs affecting foetus 5
METHYLPREDNISOLONE. Myopathy 5
METHYLPREDNISOLONE. Nephropathy toxic 5
METHYLPREDNISOLONE. Pain 5
METHYLPREDNISOLONE. Pain in extremity 5

Total Records: 857     Number of Pages: 43